MedTrace Logo

Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin

NCT01437670 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 262

Last updated 2014-05-30

No results posted yet for this study

Summary

A prospective, multicenter, observation study to estimate the dry mouth in OAB patients with solifenacin

Conditions

Interventions

DRUG

solifenacin 5mg, 10mg

solifenacin 5mg, 10mg

Sponsors & Collaborators

  • Samsung Medical Center

    collaborator OTHER

  • Seoul National University Hospital

    collaborator OTHER

  • The Catholic University of Korea

    collaborator OTHER

  • Ajou University

    collaborator OTHER

  • Severance Hospital

    collaborator OTHER

  • Cheil General Hospital and Women's Healthcare Center

    collaborator OTHER

  • SMG-SNU Boramae Medical Center

    collaborator OTHER

  • Pusan National University Yangsan Hospital

    collaborator OTHER

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Myoung-Soo Choo, M.D., pH.D. · Asan Medical Center

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-08-31
Completion
2013-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01437670 on ClinicalTrials.gov